Skip to main content

Advertisement

Log in

Safety and efficacy of salvage high-dose rate brachytherapy for prostate-bed recurrences following radical prostatectomy and external beam radiotherapy

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

This retrospective study aims to evaluate the efficacy and safety of salvage HDR brachytherapy in second local recurrences of prostate cancer after applying radical prostatectomy (RP) and post-operative external beam radiotherapy (EBRT).

Materials and methodology

Fifteen patients with locally recurrent prostate cancer after RP and EBRT were salvaged with HDR brachytherapy. Patients had no nodal or distant metastasis evidence on imaging findings, including whole body bone scan, CT scan, and MRI or PSMA PET scan. HDR brachytherapy was applied with 36 Gy in four fractions, in two implantations with 1 week apart. We followed the patients for a control visit every 3 months for 2 years, and every 6 months thereafter.

Results

Fifteen patients with the mean age of 64 years (ranged 51–79) underwent salvage HDR brachytherapy. The mean baseline level of PSA was calculated 2.26 ng/ml (ranged from 0.21 to 9, SD = 2.33), which has been significantly decreased in all patients. Hence, two of our patients experienced a biochemical failure during the follow-up period. Our results showed that 86.6% (n = 13) of patients had never experienced a significant increment in PSA level after a median follow-up of 48 months (ranging from 12 to 132 months). Besides, salvage HDR brachytherapy did not induce any significant side effects such as acute or late rectal complications, despite causing urinary complication.

Conclusions

HDR brachytherapy could be considered as a treatment in well-selected patients with the second recurrence in their prostatic bed after the former EBRT allowing for dose escalating to the second nodular recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hamdy FC, Donovan JL, Lane JA et al (2016) 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415–1424. https://doi.org/10.1056/NEJMOA1606220

    Article  PubMed  Google Scholar 

  2. Boorjian SA, Thompson RH, Siddiqui S et al (2007) Long-Term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178:864–871. https://doi.org/10.1016/j.juro.2007.05.048

    Article  PubMed  Google Scholar 

  3. Bianco FJ, Scardino PT, Eastham JA (2005) Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66:83–94. https://doi.org/10.1016/j.urology.2005.06.116

    Article  PubMed  Google Scholar 

  4. Chun FK-H, Graefen M, Zacharias M et al (2006) Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer. World J Urol 2006(24):273–280. https://doi.org/10.1007/S00345-006-0058-2

    Article  Google Scholar 

  5. Han M, Partin AW, Pound CR et al (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin N Am 28:555–565. https://doi.org/10.1016/S0094-0143(05)70163-4

    Article  CAS  Google Scholar 

  6. Pisansky TM, Thompson IM, Valicenti RK et al (2019) Adjuvant and salvage radiotherapy after prostatectomy: astro/aua guideline amendment 2018–2019. J Urol 202:533–538. https://doi.org/10.1097/JU.0000000000000295

    Article  PubMed Central  PubMed  Google Scholar 

  7. Yamada Y, Kollmeier MA, Pei X et al (2014) A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy 13:111–116. https://doi.org/10.1016/j.brachy.2013.11.005

    Article  PubMed  Google Scholar 

  8. Hennequin C, Hannoun-Lévi JM, Rozet F (2017) Management of local relapse after prostate cancer radiotherapy: surgery or radiotherapy? Cancer/Radiothérapie 21:433–436. https://doi.org/10.1016/J.CANRAD.2017.07.026

    Article  CAS  Google Scholar 

  9. Chen CP, Weinberg V, Shinohara K et al (2013) Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys 86:324–329. https://doi.org/10.1016/j.ijrobp.2013.01.027

    Article  PubMed  Google Scholar 

  10. Thiruthaneeswaran N, Hoskin PJ (2016) High dose rate brachytherapy for prostate cancer: standard of care and future direction. Cancer/Radiotherapie 20:66–72

    Article  CAS  Google Scholar 

  11. Kumar AMS, Smith KL, Reddy CA et al (2015) Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy. J Contemp Brachyther 7:241–246. https://doi.org/10.5114/jcb.2015.54050

    Article  Google Scholar 

  12. Bomers JGR, Overduin CG, Jenniskens SFM et al (2020) Focal Salvage MR Imaging-Guided Cryoablation for Localized Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up. J Vasc Interv Radiol 31:35–41. https://doi.org/10.1016/J.JVIR.2019.07.001

  13. Gelet A, Chapelon JY, Poissonnier L et al (2004) Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63:625–629. https://doi.org/10.1016/J.UROLOGY.2004.01.002

  14. Murat FJ, Poissonnier L, Rabilloud M et al (2009) Mid-term results demonstrate salvage high- intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 55:640–649. https://doi.org/10.1016/J.EURURO.2008.04.091

  15. Gomez-Veiga F, Mariño A, Alvarez L et al (2012) Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy. BJU Int 109:17–21. https://doi.org/10.1111/j.1464-410X.2011.10826.x

    Article  PubMed  Google Scholar 

  16. Losa A, Nava LD, Di Muzio N et al (2003) Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy. Urology 62:1068–1072. https://doi.org/10.1016/S0090-4295(03)00784-2

    Article  PubMed  Google Scholar 

  17. Cuccia F, Mazzola R, Nicosia L et al (2020) Prostate re-irradiation: current concerns and future perspectives. Expert Rev Anticancer Ther 20:947–956. https://doi.org/10.1080/14737140.2020.1822742

    Article  CAS  PubMed  Google Scholar 

  18. Burri RJ, Stone NN, Unger P, Stock RG (2010) Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77:1338–1344. https://doi.org/10.1016/j.ijrobp.2009.06.061

    Article  PubMed  Google Scholar 

  19. Kwok Y, Narang M, Molitoris JK (2019) Salvage prostate brachytherapy after definitive external radiation: tried and now tested. Transl Androl Urol 8:S232. https://doi.org/10.21037/TAU.2019.01.12

    Article  PubMed Central  PubMed  Google Scholar 

  20. Henríquez I, Sancho G, Hervás A et al (2014) Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol 91(9):1–8. https://doi.org/10.1186/1748-717X-9-102

    Article  CAS  Google Scholar 

  21. Chiarlone R, Vallerga F, Arboscello C et al (2017) Salvage LDR brachytherapy in local relapse after radical prostatectomy. Brachytherapy 16:S116. https://doi.org/10.1016/J.BRACHY.2017.04.227

    Article  Google Scholar 

  22. Chitmanee P, Tsang Y, Tharmalingam H et al (2020) Single-dose focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clin Oncol 32:259–265. https://doi.org/10.1016/j.clon.2019.10.008

    Article  CAS  Google Scholar 

  23. Schönle N, Strnad V, Lotter M et al (2020) Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer. Radiother Oncol 150:201–205. https://doi.org/10.1016/J.RADONC.2020.06.031

    Article  PubMed  Google Scholar 

  24. Cuccia F, Nicosia L, Mazzola R et al (2020) Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer. Strahlentherapie und Onkol 196:628–636. https://doi.org/10.1007/s00066-020-01628-6

    Article  Google Scholar 

Download references

Acknowledgements

The authors are thankful to the patients and hospital staff for their collaboration.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mahdi Aghili or Fatemeh Jafari.

Ethics declarations

Conflict of interest

All the authors of this manuscript declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aghili, M., Jafari, F., Yamrali, M. et al. Safety and efficacy of salvage high-dose rate brachytherapy for prostate-bed recurrences following radical prostatectomy and external beam radiotherapy. Int Urol Nephrol 54, 1031–1037 (2022). https://doi.org/10.1007/s11255-022-03155-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-022-03155-y

Keywords

Navigation